| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Pathology, New York University School of Medicine, New York, New York
Abstract
Administration of heparin or warfarin to sensitized guinea pigs resulted in diminution or prevention of delayed sensitivity reactions. This effect was found in animals sensitized either to a protein conjugate (DNP-BGG) or to a contact-sensitizing chemical (OCBC). Guinea pigs recovered quickly from the inhibitory effect of heparin, paralleling the return to normal of the coagulation time. The amount of heparin employed in these experiments did not result in depression of serum complement levels.
The administration of chondroitin sulfate, a compound structurally similar to heparin but lacking its anticoagulant action, had no effect on contact sensitivity reactions.
Heparin treatment of contact sensitive guinea pigs did not interfere with the capacity of their lymph node cells to transfer contact reactivity to normal recipients.
Heparin failed to inhibit nonimmunologic inflammatory reactions elicited by bovine fibrinogen or poly-L-lysine, although these reactions bore some gross and histologic resemblance to delayed reactions.
The inhibition of dermal hypersensitivity reactions (DNP-BGG) by heparin was not accompanied by an interference with the booster effect of the skin test on the production of circulating anti-DNP antibodies.
It is concluded that heparin and warfarin exert their inhibitory effect on delayed reactivity through some action on the coagulation mechanism which probably results either in the prevention of accumulation of immunologically nonspecific inflammatory cells or somehow blocks the triggering events initiated by interaction of antigen with sensitized cells.
Footnotes
Supported by U.S.P.H.S. Grant No. A.M. 01395 and by the Health Research Council of the City of New York under Contracts No. I-138 and I-140.
This article has been cited by other articles:
|
|
 |
|
  F. M. Szaba and S. T. Smiley Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo Blood, February 1, 2002; 99(3): 1053 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G.P. Welt, T. C. Woods, and E. R. Edelman Oral Heparin Prevents Neointimal Hyperplasia After Arterial Injury: Inhibitory Potential Depends on Type of Vascular Injury Circulation, December 18, 2001; 104(25): 3121 - 3124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Liu and T. H. Piela-Smith Fibrin(ogen)-Induced Expression of ICAM-1 and Chemokines in Human Synovial Fibroblasts J. Immunol., November 1, 2000; 165(9): 5255 - 5261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. O'Regan, G. L. Chupp, J. A. Lowry, M. Goetschkes, N. Mulligan, and J. S. Berman Osteopontin Is Associated with T Cells in Sarcoid Granulomas and Has T Cell Adhesive and Cytokine-Like Properties In Vitro J. Immunol., January 15, 1999; 162(2): 1024 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Smiley, S. N. Boyer, M. J. Heeb, J. H. Griffin, and M. J. Grusby Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity PNAS, October 14, 1997; 94(21): 11484 - 11489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rogers, F. G.P. Welt, M. J. Karnovsky, and E. R. Edelman Monocyte Recruitment and Neointimal Hyperplasia in Rabbits: Coupled Inhibitory Effects of Heparin Arterioscler Thromb Vasc Biol, October 1, 1996; 16(10): 1312 - 1318. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. R. Ahmed and D. A. Blose Delayed-Type Hypersensitivity Skin Testing: A Review Arch Dermatol, November 1, 1983; 119(11): 934 - 945. [Abstract] [PDF]
|
|
|
|
|
|
T. Horio, S. Imamura, K. Danno, and S. Ofuji Potassium Iodide in the Treatment of Erythema Nodosum and Nodular Vasculitis Arch Dermatol, January 1, 1981; 117(1): 29 - 31. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Chelmicka-Szorc and B. G. W. Arnason Partial Suppression of Experimental Allergic Encephalomyelitis With Heparin Arch Neurol, August 1, 1972; 27(2): 153 - 158. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
